pilocarpine has been researched along with remoxipride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clinckers, R; Ebinger, G; Meurs, A; Michotte, Y; Smolders, I | 2 |
2 other study(ies) available for pilocarpine and remoxipride
| Article | Year |
|---|---|
Anticonvulsant action of GBR-12909 and citalopram against acute experimentally induced limbic seizures.
Topics: Acute Disease; Animals; Anticonvulsants; Biogenic Monoamines; Citalopram; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Hippocampus; Limbic System; Male; Microdialysis; Muscarinic Agonists; Pilocarpine; Piperazines; Pyridines; Rats; Rats, Wistar; Remoxipride; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 2004 |
Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y.
Topics: Analysis of Variance; Animals; Anticonvulsants; Behavior, Animal; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Epilepsy; Ethylenediamines; Hippocampus; Male; Microdialysis; Neuropeptide Y; Pilocarpine; Rats; Rats, Wistar; Receptors, sigma; Remoxipride; Severity of Illness Index; Sigma-1 Receptor; Time Factors | 2007 |